These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Signifance of diffusion capacity for the diagnosis of lung diseases]. Bergstermann H; Emslander HP MMW Munch Med Wochenschr; 1974 Jan; 116(4):151-8. PubMed ID: 4206047 [No Abstract] [Full Text] [Related]
46. [Idiopathic pulmonary fibrosis: from biopathology to treatment]. Wallaert B; Lamblin C Rev Prat; 2000 Nov; 50(17):1906-10. PubMed ID: 11151332 [TBL] [Abstract][Full Text] [Related]
52. [Open lung bioasy. An extension of diagnostic possibilities in the clinical therapy of lung diseases]. Freise G; Gabler A Munch Med Wochenschr; 1968 Jul; 110(28):1629-41. PubMed ID: 5303282 [No Abstract] [Full Text] [Related]
53. Type II pneumocyte injury in human respiratory diseases. Chrétien J; Jaubert F; Basset F Curr Probl Clin Biochem; 1983; 13():56-72. PubMed ID: 6653150 [No Abstract] [Full Text] [Related]
54. [Morphology of fibrosing lung diseases]. Müller KM Pneumologie; 1991 Jun; 45(6):466-9. PubMed ID: 1924216 [No Abstract] [Full Text] [Related]
55. The pulmonary interstitium in pathological states. Turner-Warwick M; Haslam PL; Heard B; Dewar A Curr Probl Clin Biochem; 1983; 13():157-67. PubMed ID: 6653145 [No Abstract] [Full Text] [Related]
56. Diseases due to immunologic reactions in the lungs. 2. McCombs RP N Engl J Med; 1972 Jun; 286(23):1245-52. PubMed ID: 4260035 [No Abstract] [Full Text] [Related]